Results 131 to 140 of about 1,702,455 (203)

The Establishment of a Novel Murine Model of Immune Thrombocytopenia in Pregnancy and the Impacts of Thrombopoietin Receptor Agonist on Platelet Production. [PDF]

Cureus
Shibata S, Kitada K, Nakai K, Uemura R, Kurihara Y, Tahara M, Hamuro A, Nakano A, Misugi T, Tachibana D.   +9 more
europepmc   +1 more source

Aplastic Anemia With Thrombosis Following the Administration of Immunosuppressant and Thrombopoietin Receptor Agonist (TPO-RA). [PDF]

Cureus
Iino T, Yokoo M, Okamoto S, Kondo S.
europepmc   +1 more source

Thrombopoietin Receptor Agonists for the treatment of ITP.

[Rinsho ketsueki] The Japanese journal of clinical hematology, 2013
openaire   +2 more sources

Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent/chronic immune thrombocytopenia: a multicenter prospective study from China. [PDF]

Res Pract Thromb Haemost
Fu L, Lin X, Chen Z, Wang Z, Liu Y, Wang L, Hu Y, Ma J, Wang N, Cheng X, Ma J, Wu R.   +11 more
europepmc   +1 more source

Thrombopoietin receptor agonists for the treatment of inherited thrombocytopenia

Haematologica, 2020
openaire   +5 more sources

Two Cases of Immune Thrombocytopenia (ITP) Related to Viral Vector Vaccination ChAdOx1-S (AstraZeneca) and a Good Response after Thrombopoietin Receptor Agonist (TPO-RA) Therapy. [PDF]

Hematol Rep
Salveridou K, Tzamalis T, Klaiber-Hakimi M, Haase S, Gröpper S, Giagounidis A.   +5 more
europepmc   +1 more source

Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia. [PDF]

Sci Rep, 2019
Lozano ML, Mingot-Castellano ME, Perera MM, Jarque I, Campos-Alvarez RM, González-López TJ, Carreño-Tarragona G, Bermejo N, Lopez-Fernandez MF, de Andrés A, Valcarcel D, Casado-Montero LF, Alvarez-Roman MT, Orts MI, Novelli S, Revilla N, González-Porras JR, Bolaños E, Rodríguez-López MA, Orna-Montero E, Vicente V.   +20 more
europepmc   +1 more source

Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist. [PDF]

J Cell Mol Med, 2018
Xie C, Zhao H, Bao X, Fu H, Lou L.
europepmc   +1 more source

Thrombopoietin Receptor Agonist LGD-4665 [PDF]

, 2020
openaire   +1 more source

Phenotype description and response to thrombopoietin receptor agonist in <i>DIAPH1</i>-related disorder. [PDF]

Blood Adv, 2018
Westbury SK, Downes K, Burney C, Lozano ML, Obaji SG, Toh CH, Sevivas T, Morgan NV, Erber WN, Kempster C, Moore SF, Thys C, Papadia S, Ouwehand WH, NIHR BioResource–Rare Diseases, Laffan MA, Gomez K, Freson K, Rivera J, Mumford AD.   +19 more
europepmc   +1 more source